Gujarat Kidney and Superspeciality Hospital to Acquire Remaining 49% Stake in Harmony Medicare

Gujarat Kidney and Superspeciality Limited has approved a key inorganic expansion move as part of its healthcare growth strategy.  

The company’s board has cleared the acquisition of the remaining equity stake in Harmony Medicare Private Limited, consolidating its control over the healthcare services entity. 

Acquisition Details and Transaction Structure 

The board has approved the purchase of the remaining 49% equity stake in Harmony Medicare Private Limited, converting it into a wholly owned subsidiary.  

Harmony Medicare is engaged in medical and healthcare services and reported a turnover of ₹42.29 crore in FY25.  

The transaction is classified as a related-party deal and is being carried out on an arm’s length basis. The acquisition is expected to be completed within approximately two months and does not require any regulatory approvals. 

Strategic Rationale and Funding 

The acquisition is aimed at strengthening Gujarat Kidney and Superspeciality’s presence in the healthcare sector and diversifying its business portfolio.  

Alongside this, the board has also approved the utilisation of IPO proceeds towards part-payment of ₹12.40 crore for the already acquired Ashwini Medical Centre.  

Ashwini Medical Centre, a medical and pharmacy services provider based in Gujarat, reported FY25 turnover of ₹4.51 crore. The remaining acquisition cost has already been paid, with the balance to be funded from the IPO. 

Read More: Gujarat Kidney Share Price Down 4% from Open Price! 

Gujarat Kidney and Super speciality Share Price Performance  

As of January 07, 2025, at 10:00 AM, Gujarat Kidney and Super Speciality share price is trading at ₹100.25 per share, reflecting a decline of 0.84% from the previous closing price.  

Conclusion 

By consolidating Harmony Medicare and integrating Ashwini Medical Centre, Gujarat Kidney and Superspeciality is reinforcing its healthcare platform and positioning itself for scaled growth through operational and financial consolidation. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.